Showing results (201-210 of 302) with videos related to

Sort By:
Pageof 31
Inflammation|April 10, 2004
Increased level of soluble E-selectin in the serum from patients with idiopathic pulmonary fibrosisSeiji Hayashi, Kin'ya Abe, Hiroto Matsuoka, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 11, 2020
Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPDMasakazu Ichinose, Yasushi Fukushima, Yoshikazu Inoue, et al.
Respiratory Medicine|January 23, 2019
Lung function outcomes in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosisKevin K Brown, Kevin R Flaherty, Vincent Cottin, et al.
American Journal of Respiratory and Critical Care Medicine|February 14, 2024
Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE TrialLuca Richeldi, Courtney Schiffman, Jürgen Behr, et al.
American Journal of Respiratory and Critical Care Medicine|April 3, 2004
Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigensToru Mori, Mitsunori Sakatani, Fumio Yamagishi, et al.
Japanese Journal of Radiology|February 28, 2020
High-resolution CT features distinguishing usual interstitial pneumonia pattern in chronic hypersensitivity pneumonitis from those with idiopathic pulmonary fibrosisTomoya Tateishi, Takeshi Johkoh, Fumikazu Sakai, et al.
Respiratory Medicine|September 19, 2025
Treatable traits in interstitial lung disease: opportunities and challengesYet H Khor, Anna J Podolanczuk, Elisabetta A Renzoni, et al.
American Journal of Respiratory and Critical Care Medicine|March 1, 2005
Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosisRyushi Tazawa, Emi Hamano, Toru Arai, et al.
The Lancet. Respiratory Medicine|March 9, 2020
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trialAthol U Wells, Kevin R Flaherty, Kevin K Brown, et al.
Plos One|January 16, 2016
Lung Transplantation for Lymphangioleiomyomatosis in JapanKatsutoshi Ando, Yoshinori Okada, Miki Akiba, et al.
Pageof 31